China To Impose Export-Licensing Requirement On Drug Industry
This article was originally published in PharmAsia News
Executive Summary
China's State Food and Drug Administration is about to test a new system of controlling drug exports on 10 pharmaceutical categories, according to the agency's director. Shao Mingli told a national food and drug conference the system would cover pharmaceutical agents and materials used to make them, plus other materials qualified for producing drugs. The new rules would require drug makers to obtain a license and register the drugs they produce, and they would have to have official qualifications and written export approval from authorities before the products can be exported. Shao also vowed to continue a crackdown on bribery, negligence and other abuses linked to the agency. (Click here for more